Thus, TMIGD3 i1 regulates the PKA−Akt−IκB−NF-κB axis, similar to A3AR, thus reiterating the significance of the GPCR-regulated NF-κB pathway as a potential target for cancer therapy. The gene discussed is NFKB1; the disease is cancer.